Byron C Calhoun1. 1. Department of Obstetrics and Gynecology, West Virginia University-Charleston, Charleston, WV, USA.
Abstract
Treatment of pulmonary hypertension in pregnancy with a prostacyclin analogue-iloprost and/or calcium channel antagonists appears to improve outcomes and survival. These medications could have been administered to the patient and the response monitored. If the patient did not respond to therapy, this patient may have had either a referral to or transfer to another high risk center with more experience in this type of pregnant patient. There is no literature to support termination of pregnancy improving maternal survival outcomes in these patients, even though termination is recommended by all obstetrical textbooks. Maternal survival, rather, appears to be related to response to therapy, type of therapy, and continuation of therapy. SUMMARY: A patient who is pregnant with pulmonary hypertension (increased right-sided heart pressures) may be managed with medications. There is no literature to support termination of pregnancy improving maternal survival outcomes in patients with pulmonary hypertension, even though termination is recommended by all obstetrical textbooks. Maternal survival, rather, appears to be related to response to therapy, type of therapy, and continuation of therapy.
Treatment of pulmonary hypertension in pregnancy with a prostacyclin analogue-iloprost and/or calcium channel antagonists appears to improve outcomes and survival. These medications could have been administered to the patient and the response monitored. If the patient did not respond to therapy, this patient may have had either a referral to or transfer to another high risk center with more experience in this type of pregnant patient. There is no literature to support termination of pregnancy improving maternal survival outcomes in these patients, even though termination is recommended by all obstetrical textbooks. Maternal survival, rather, appears to be related to response to therapy, type of therapy, and continuation of therapy. SUMMARY: A patient who is pregnant with pulmonary hypertension (increased right-sided heart pressures) may be managed with medications. There is no literature to support termination of pregnancy improving maternal survival outcomes in patients with pulmonary hypertension, even though termination is recommended by all obstetrical textbooks. Maternal survival, rather, appears to be related to response to therapy, type of therapy, and continuation of therapy.
Authors: C A Elliot; P Stewart; V J Webster; G H Mills; S P Hutchinson; E S Howarth; F A Bu'lock; R A Lawson; I J Armstrong; D G Kiely Journal: Eur Respir J Date: 2005-07 Impact factor: 16.671
Authors: T Gessler; T Schmehl; M M Hoeper; F Rose; H A Ghofrani; H Olschewski; F Grimminger; W Seeger Journal: Eur Respir J Date: 2001-01 Impact factor: 16.671
Authors: H Olschewski; H A Ghofrani; T Schmehl; J Winkler; H Wilkens; M M Höper; J Behr; F X Kleber; W Seeger Journal: Ann Intern Med Date: 2000-03-21 Impact factor: 25.391
Authors: D G Kiely; R Condliffe; V Webster; G H Mills; I Wrench; S V Gandhi; K Selby; I J Armstrong; L Martin; E S Howarth; F A Bu'lock; P Stewart; C A Elliot Journal: BJOG Date: 2010-04 Impact factor: 6.531
Authors: E McMillan; W L Martin; J Waugh; I Rushton; M Lewis; T Clutton-Brock; J N Townend; M D Kilby; C Gordon Journal: Lupus Date: 2002 Impact factor: 2.911
Authors: S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner Journal: Ann Intern Med Date: 1987-08 Impact factor: 25.391